BIO Medical Applications Of Texas, Inc is a medicare approved dialysis facility center in Lubbock, Texas and it has 13 dialysis stations. It is located in Lubbock county at 8704 University Ave, Lubbock, TX, 79423. You can reach out to the office of BIO Medical Applications Of Texas, Inc at (806) 748-0002. This dialysis clinic is managed and/or owned by Fresenius Medical Care. BIO Medical Applications Of Texas, Inc has the following ownership type - Profit. It was first certified by medicare in May, 2017. The medicare id for this facility is 672811 and it accepts patients under medicare ESRD program.
| Name | BIO Medical Applications Of Texas, Inc |
|---|---|
| Location | 8704 University Ave, Lubbock, Texas |
| No. of Dialysis Stations | 13 |
| Medicare ID | 672811 |
| Managed By | Fresenius Medical Care |
| Ownership Type | Profit |
| Late Shifts | Yes |
| 8704 University Ave, Lubbock, Texas, 79423 | |
| (806) 748-0002 | |
| Not Available |
News Archive
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced The 2013 AEIRS/Elsevier Innovator of the Year Award recipients. Mahsa Dehghanpour, EDd, MS, CMD, Program Director and Assistant Professor, and Jamie Baker, MEd, CMD, Instructor and Education Coordinator, both of the Medical Dosimetry Program at the University of Texas MD Anderson Cancer Center School of Health Professions (SHP), have been recognized for their outstanding work as educators in imaging sciences.
A new study by a team of University of Notre Dame researchers, which appears in the Sept. 2 edition of the journal PLoS ONE, is a significant step in understanding the molecular genetic and physiological basis for a spectrum of metabolic diseases related to circadian function.
An unusual autoimmune disease that causes skin and lung damage can be treated effectively by stem cell transplant, a new study in the New England Journal of Medicine has found.
In the COVID-19 pandemic, 57 million people have already been infected worldwide. In the search for vaccines and therapies, a precise understanding of the virus, its mutations, and transmission mechanisms are crucial.
Patients with an out-of-hospital cardiac arrest who received intravenous (IV) drug administration during treatment, recommended in life support guidelines, had higher rates of short term survival but no statistically significant improvement in survival to hospital discharge or long-term survival, compared to patients who did not receive IV drug administration, according to a study in the November 25 issue of JAMA.
› Verified 7 days ago
| NPI Number | 1235685470 |
| Organization Name | Fresenius Kidney Care Caprock |
| Doing Business As | Bio-medical Applications Of Texas, Inc. |
| Address | 8704 University Ave Lubbock, Texas, 79423 |
| Phone Number | (806) 748-0002 |
News Archive
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced The 2013 AEIRS/Elsevier Innovator of the Year Award recipients. Mahsa Dehghanpour, EDd, MS, CMD, Program Director and Assistant Professor, and Jamie Baker, MEd, CMD, Instructor and Education Coordinator, both of the Medical Dosimetry Program at the University of Texas MD Anderson Cancer Center School of Health Professions (SHP), have been recognized for their outstanding work as educators in imaging sciences.
A new study by a team of University of Notre Dame researchers, which appears in the Sept. 2 edition of the journal PLoS ONE, is a significant step in understanding the molecular genetic and physiological basis for a spectrum of metabolic diseases related to circadian function.
An unusual autoimmune disease that causes skin and lung damage can be treated effectively by stem cell transplant, a new study in the New England Journal of Medicine has found.
In the COVID-19 pandemic, 57 million people have already been infected worldwide. In the search for vaccines and therapies, a precise understanding of the virus, its mutations, and transmission mechanisms are crucial.
Patients with an out-of-hospital cardiac arrest who received intravenous (IV) drug administration during treatment, recommended in life support guidelines, had higher rates of short term survival but no statistically significant improvement in survival to hospital discharge or long-term survival, compared to patients who did not receive IV drug administration, according to a study in the November 25 issue of JAMA.
› Verified 7 days ago
| Dialysis patients with Hemoglobin data | 4 |
News Archive
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced The 2013 AEIRS/Elsevier Innovator of the Year Award recipients. Mahsa Dehghanpour, EDd, MS, CMD, Program Director and Assistant Professor, and Jamie Baker, MEd, CMD, Instructor and Education Coordinator, both of the Medical Dosimetry Program at the University of Texas MD Anderson Cancer Center School of Health Professions (SHP), have been recognized for their outstanding work as educators in imaging sciences.
A new study by a team of University of Notre Dame researchers, which appears in the Sept. 2 edition of the journal PLoS ONE, is a significant step in understanding the molecular genetic and physiological basis for a spectrum of metabolic diseases related to circadian function.
An unusual autoimmune disease that causes skin and lung damage can be treated effectively by stem cell transplant, a new study in the New England Journal of Medicine has found.
In the COVID-19 pandemic, 57 million people have already been infected worldwide. In the search for vaccines and therapies, a precise understanding of the virus, its mutations, and transmission mechanisms are crucial.
Patients with an out-of-hospital cardiac arrest who received intravenous (IV) drug administration during treatment, recommended in life support guidelines, had higher rates of short term survival but no statistically significant improvement in survival to hospital discharge or long-term survival, compared to patients who did not receive IV drug administration, according to a study in the November 25 issue of JAMA.
› Verified 7 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 17 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 57 |
| Percentage of adult patients getting regular hemodialysis at the center | 86 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced The 2013 AEIRS/Elsevier Innovator of the Year Award recipients. Mahsa Dehghanpour, EDd, MS, CMD, Program Director and Assistant Professor, and Jamie Baker, MEd, CMD, Instructor and Education Coordinator, both of the Medical Dosimetry Program at the University of Texas MD Anderson Cancer Center School of Health Professions (SHP), have been recognized for their outstanding work as educators in imaging sciences.
A new study by a team of University of Notre Dame researchers, which appears in the Sept. 2 edition of the journal PLoS ONE, is a significant step in understanding the molecular genetic and physiological basis for a spectrum of metabolic diseases related to circadian function.
An unusual autoimmune disease that causes skin and lung damage can be treated effectively by stem cell transplant, a new study in the New England Journal of Medicine has found.
In the COVID-19 pandemic, 57 million people have already been infected worldwide. In the search for vaccines and therapies, a precise understanding of the virus, its mutations, and transmission mechanisms are crucial.
Patients with an out-of-hospital cardiac arrest who received intravenous (IV) drug administration during treatment, recommended in life support guidelines, had higher rates of short term survival but no statistically significant improvement in survival to hospital discharge or long-term survival, compared to patients who did not receive IV drug administration, according to a study in the November 25 issue of JAMA.
› Verified 7 days ago
| Adult patients getting regular peritoneal dialysis at the center | 28 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 42 |
| Percentage of adult patients getting regular peritoneal dialysis at the center | 81 |
| Percentage of pediatric patients getting regular peritoneal dialysis at the center |
News Archive
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced The 2013 AEIRS/Elsevier Innovator of the Year Award recipients. Mahsa Dehghanpour, EDd, MS, CMD, Program Director and Assistant Professor, and Jamie Baker, MEd, CMD, Instructor and Education Coordinator, both of the Medical Dosimetry Program at the University of Texas MD Anderson Cancer Center School of Health Professions (SHP), have been recognized for their outstanding work as educators in imaging sciences.
A new study by a team of University of Notre Dame researchers, which appears in the Sept. 2 edition of the journal PLoS ONE, is a significant step in understanding the molecular genetic and physiological basis for a spectrum of metabolic diseases related to circadian function.
An unusual autoimmune disease that causes skin and lung damage can be treated effectively by stem cell transplant, a new study in the New England Journal of Medicine has found.
In the COVID-19 pandemic, 57 million people have already been infected worldwide. In the search for vaccines and therapies, a precise understanding of the virus, its mutations, and transmission mechanisms are crucial.
Patients with an out-of-hospital cardiac arrest who received intravenous (IV) drug administration during treatment, recommended in life support guidelines, had higher rates of short term survival but no statistically significant improvement in survival to hospital discharge or long-term survival, compared to patients who did not receive IV drug administration, according to a study in the November 25 issue of JAMA.
› Verified 7 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at BIO Medical Applications Of Texas, Inc with elevated calcium levels.
| Patients with hypercalcemia | 47 |
| Hypercalcemia patient months | 104 |
| Hypercalcemia patients with serumcalcium greater than 10.2 mg | 1 |
| Patients with Serumphosphor | 56 |
| Patients with Serumphosphor less than 3.5 mg/dL | 10 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 22 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 29 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 27 |
| Patients with Serumphosphor greater than 7 mg/dL | 12 |
News Archive
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced The 2013 AEIRS/Elsevier Innovator of the Year Award recipients. Mahsa Dehghanpour, EDd, MS, CMD, Program Director and Assistant Professor, and Jamie Baker, MEd, CMD, Instructor and Education Coordinator, both of the Medical Dosimetry Program at the University of Texas MD Anderson Cancer Center School of Health Professions (SHP), have been recognized for their outstanding work as educators in imaging sciences.
A new study by a team of University of Notre Dame researchers, which appears in the Sept. 2 edition of the journal PLoS ONE, is a significant step in understanding the molecular genetic and physiological basis for a spectrum of metabolic diseases related to circadian function.
An unusual autoimmune disease that causes skin and lung damage can be treated effectively by stem cell transplant, a new study in the New England Journal of Medicine has found.
In the COVID-19 pandemic, 57 million people have already been infected worldwide. In the search for vaccines and therapies, a precise understanding of the virus, its mutations, and transmission mechanisms are crucial.
Patients with an out-of-hospital cardiac arrest who received intravenous (IV) drug administration during treatment, recommended in life support guidelines, had higher rates of short term survival but no statistically significant improvement in survival to hospital discharge or long-term survival, compared to patients who did not receive IV drug administration, according to a study in the November 25 issue of JAMA.
› Verified 7 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 22 |
| Patient months included in arterial venous fistula and catheter summaries | 51 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 61 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 6 |
News Archive
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced The 2013 AEIRS/Elsevier Innovator of the Year Award recipients. Mahsa Dehghanpour, EDd, MS, CMD, Program Director and Assistant Professor, and Jamie Baker, MEd, CMD, Instructor and Education Coordinator, both of the Medical Dosimetry Program at the University of Texas MD Anderson Cancer Center School of Health Professions (SHP), have been recognized for their outstanding work as educators in imaging sciences.
A new study by a team of University of Notre Dame researchers, which appears in the Sept. 2 edition of the journal PLoS ONE, is a significant step in understanding the molecular genetic and physiological basis for a spectrum of metabolic diseases related to circadian function.
An unusual autoimmune disease that causes skin and lung damage can be treated effectively by stem cell transplant, a new study in the New England Journal of Medicine has found.
In the COVID-19 pandemic, 57 million people have already been infected worldwide. In the search for vaccines and therapies, a precise understanding of the virus, its mutations, and transmission mechanisms are crucial.
Patients with an out-of-hospital cardiac arrest who received intravenous (IV) drug administration during treatment, recommended in life support guidelines, had higher rates of short term survival but no statistically significant improvement in survival to hospital discharge or long-term survival, compared to patients who did not receive IV drug administration, according to a study in the November 25 issue of JAMA.
› Verified 7 days ago